Clinical Trial Update: Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life [Phase 4]

View source ↗

Summary

A Phase 4 trial update on preventing transcutaneous sensitization in children with atopic dermatitis during their first year of life has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: National Medical Research Center for Children's Health, Russian Federation | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED